Fritextsökning
Innehållstyper
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Schizophrenia and bipolar disorder are relatives
Schizophrenia and bipolar disorder have the same genetic causes, according to a study from Karolinska Institutet.
-
Nytt namn i Symphogens ledning
Adriann Sax har utsetts till affärschef på det danska företaget.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Less scars with new product
A new Swedish product for post surgical scar formation enters clinical development.
-
Raysearch igång i Kina
Första patienten ombord i strålstudie.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Samarbetar kring autofagi
Sprint Bioscience tecknar avtal med KI-professorn Dan Grander och rekryterar ny medarbetare.
-
Aprea sparkar igång studie
Första patienten doserad i fas Ib/II-studien med cancerbehandlingen APR-246.
-
Seminar program Biotech Forum
Here is the entire seminar program at Biotech Forum September 28-29th
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Lämnar över rodret på Vivolux
- Samarbetet med ledande cancerinstitut i USA och det nätverk jag byggt upp ger fina ingångar för Abigo, säger Hans Rosén, som lämnar rollen som vd på läkemedel...
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Stöd till kvinnliga forskare
17 kvinnliga forskare får halva lönen betald för att jobba i en ledande forskningsmiljö i Vinnova-programmet Vinnmer.
-
Raysearch tappar chef
Finanschefen lämnar medtechbolaget i april.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
Han leder nya Göteborgscentret
Professor Göran Landberg har utsetts till föreståndare för det nya Wallenbergcentret för molekylär och translationell medicin.
-
Kliniska studier på cancer mer positiva än verkligheten
Yngre, friskare och mer välutbildade patienter förbättrar resultaten när cancerbehandlingar testas i kliniska studier. Det menar två cancerläkare i en artikel s...
-
Lägger ner studie
Bioinvent avslutar en studie med antikroppen BI-505 mot blodcancerformen asymtomatiskt multipelt myelom.
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Your partnering tool - step by step
Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!
-
Woman deficit in Swedish research
The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.